600 extractive question-and-answer pairs built from amr17, published by ncdc.mohfw.gov.in. The source is a 157-page publication. Source-evidenced topics include first line, etiological agents, see annexure, common etiological agents, common etiological, staphylococcus aureus, infectious diseases, additional information. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. Question types in the export: 248 factual, 181 list, 67 relationship, 42 table, 38 summary, 19 definition, 5 comparison. 310 of the 600 pairs (51.7%) ask explanatory questions; the remaining 290 are factual or table-based questions. 99.67% of rows pass the corpus quality gate.
This dataset contains 600 extractive question-and-answer pairs derived from the AMR17 publication by the National Centre for Disease Control (NCDC). The dataset spans various topics related to antimicrobial resistance, infectious diseases, and treatment guidelines. Each answer is a verbatim excerpt from the source document, ensuring traceability to the original text. Questions are categorized into types such as factual, list, relationship, and summary, with explanatory questions making up 51.7% of the dataset. The dataset is designed to support research and validation in healthcare and antimicrobial stewardship.
Browse more health datasets, including other records from the same source when available.
Explore Health datasets5 - Question and Answer Dataset
Economy · 159 rows
LRF Outlook for Second Half of SW Monsoon Season: 2010 - Question and Answer Dataset
Economy · 30 rows
air2 - Question and Answer Dataset
Health · 169 rows
Microsoft Word - Brief note on NCDC Cooler.doc - pdfMachine from Broadgun Software, http://pdfmachine.com, a great PDF writer utility! - Question and Answer Dataset
Health · 12 rows
NFHS-5 Dataset
Health · 3.8K+ rows
National Health Profile 2022 - Question and Answer Dataset
Health · 5.7K+ rows
National Health Profile 2022 — Question and Answer Dataset
Health · 5.7K+ rows
XVFC VOL I Main Report - Question and Answer Dataset
Health · 1.7K+ rows
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/ncdc-mohfw-gov-in-4a3f1e9cde19a576f0ec83d3868a80dc/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("ncdc-mohfw-gov-in-4a3f1e9cde19a576f0ec83d3868a80dc")
df.head()First 10 of 600 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_document | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| What is the recommendation for the use of adjunctive intraventricular antibiotics in treating CSF shunt infections? | not routinely necessary for treatment of CSF shunt infections | The shunt should be sent for cultures. Adjunctive intraventricular antibiotics are not routinely necessary for treatment of CSF shunt infections. Intraventricular antibiotics may be required for: infections that are refractory to appropriate systemic antibiotic therapy, infections caused by highly resistant organisms susceptible only to antimicrobials with poor CSF penetration, and infections in which the shunt cannot be removed. | 83 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Adjunctive intraventricular antibiotics are not routinely necessary for treatment of CSF shunt infections. | 28 | page=28,block=3 | 0.850 | valid |
| What is the recommended course of action if complete surgical debridement for mucormycosis is not performed? | not done or not possible then therapy should be continued till radiological resolution | Duration of therapy for mucormycosis is difficult to define, but in general 2 weeks, after complete surgical debridement is advised. If complete surgical debridement is not done or not possible then therapy should be continued till radiological resolution. For common etiological agents of Invasive Fungal Infections in immunocompromised hosts, see Annexure B.17.4 References: | 169 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | If complete surgical debridement is not done or not possible then therapy should be continued till radiological resolution. | 107 | page=107,block=2 | 0.850 | valid |
| What is antimicrobial resistance considered to be in terms of global health? | a major global health threat | Introduction Antimicrobial resistance (AMR) is a major global health threat overshadowing the potential gains made since the discovery of antimicrobials. The Global Burden Disease study on antimicrobial resistance conducted in 2021 reported that 4.71 million deaths were associated with bacterial AMR including 1.14 million deaths attributable to bacterial AMR. AMR threatens all age groups of people in all regions, with low- and middle-income countries most affected, making it a major socio-economic problem. The emergence of various multi-drug-resistant organisms (MDROs), commonly referred to as "superbugs" are further complicating the problem, making common infections much more difficult to treat. | 47 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Introduction Antimicrobial resistance (AMR) is a major global health threat overshadowing the potential gains made since the discovery of antimicrobials. | 17 | page=17,block=2 | 0.700 | valid |
| What is the focus of guidance provided by the updated guidelines? | the empiric use of antimicrobials where the severity of infections mandate initiation of antimicrobials before culture and antimicrobial sensitivity results are available | from across the country, this updated version of the guidelines has been developed. These guidelines are expected to help in establishing consistency across the country for the empiric treatment of commonly identified infectious disease syndromes and ensure timely management of such patients. This ‘National Treatment Guidelines for Antimicrobial use in Common Infectious Disease Syndromes’ (Version 2.0) aims to guide the empiric use of antimicrobials where the severity of infections mandate initiation of antimicrobials before culture and antimicrobial sensitivity results are available. These guidelines list the recommended empiric treatments for common infectious disease syndromes while results of cultures of clinical samples are awaited. | 420 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | This ‘National Treatment Guidelines for Antimicrobial use in Common Infectious Disease Syndromes’ (Version 2.0) aims to guide the empiric use of antimicrobials where the severity of infections mandate initiation of antimicrobials before culture and antimicrobial sensitivity results are available. | ||||
| What is the purpose of the Centor Score (Modified/McIsaac)? | to estimate the probability of Group A Streptococcus (GAS) pharyngitis and suggest further management course. | Penicillin G 50000 units/kg IV 12 hrly Diphtheria antitoxin: Horse serum < 48 hours: 20,000-40,000 units, Nasopharyngeal membranes: 40,000- 60,000 units >3 days and bull neck: 80,000-1,20,000 units • Centor Score (Modified/McIsaac): is used to estimate the probability of Group A Streptococcus (GAS) pharyngitis and suggest further management course. Clinical variables Score Age: 3-14 years 14-44 years >44 years 1 0 -1 High fever (>100. F) 1 Tonsillar Exudate 1 Absence of cough 1 Presence of Lymphadenopathy 1 Interpretation of Centor Score: o Low risk (0-1): A low Centor score suggests a low probability of strep throat, and further testing or antibiotic treatment may not be necessary. o Moderate risk (2): A score of 2 indicates a moderate risk. | 241 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Penicillin G 50000 units/kg IV 12 hrly Diphtheria antitoxin: Horse serum < 48 hours: 20,000-40,000 units, Nasopharyngeal membranes: 40,000- 60,000 units >3 days and bull neck: 80,000-1,20,000 units • Centor Score (Modified/McIsaac): is used to estimate the probability of Group A Streptococcus (GAS) pharyngitis and suggest further management course. Clinical variables Score Age: 3-14 years 14-44 years >44 years 1 0 -1 High fever (>100. | ||||
| What trends are monitored by NARS-NET under the coordination of NCDC? | trends of antimicrobial resistance in commonly isolated pathogens | The National Treatment Guidelines for Antimicrobial Use in Infectious Diseases was released in 2016 by National Centre for Disease Control. Indian Council of Medical Research in 2017 published Treatment Guidelines for Antimicrobial Use in Common Syndromes and 2nd edition of the same was released in 2019. Based on the trends of antimicrobial resistance in commonly isolated pathogens being tracked under NARS-NET coordinated by NCDC and AMRSN coordinated by ICMR and inputs from clinical experts | 319 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Based on the trends of antimicrobial resistance in commonly isolated pathogens being tracked under NARS-NET coordinated by NCDC and AMRSN coordinated by ICMR and inputs from clinical experts | 17 | page=17,block=7 | 0.700 | valid |
| What type of inflammation do viruses usually not cause in the eye? | suppurative inflammation of the eye or endophthalmitis | examinations to assess treatment response. For common etiological agents of endophthalmitis, see Annexure B.11. Additional Information: • Viruses usually do not cause suppurative inflammation of the eye or endophthalmitis. | 167 | definition | 1.000 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Additional Information: • Viruses usually do not cause suppurative inflammation of the eye or endophthalmitis. | 84 | page=84,block=2 | 0.700 | valid |
| What is CMV manageme nt Letermovir prophylaxis? | the preferred approach for allogenic HSCT hosts | Duration: typically given till engraftment; but may be prolonged if used as secondary prophylaxis or concomitant GVHD Antiviral prophylaxis Acyclovir 400mg BD Continued in the post-transplant period for 6 months for autologous and 1 year for allogeneic BMT. CMV manageme nt Letermovir prophylaxis is the preferred approach for allogenic HSCT hosts. If prophylaxis not feasible, follow pre- emptive strategy. | 300 | definition | 0.980 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | CMV manageme nt Letermovir prophylaxis is the preferred approach for allogenic HSCT hosts. | 108 | page=108,block=1 | 0.850 | valid |
| What is Surgery? | the cornerstone of treatment for deep diabetic foot infections | aureus if necessary, and Streptococci. Surgery is the cornerstone of treatment for deep diabetic foot infections. Procedures range from simple incision and drainage to extensive multiple surgical debridement and amputation. | 50 | definition | 0.980 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Surgery is the cornerstone of treatment for deep diabetic foot infections. | 65 | page=65,block=3 | 0.850 | valid |
| How is puerperal sepsis defined? | ‘a serious infection of the genital tract which occurs within 42 days of delivery | Type of Infection First Line (with Dosage and Duration) Alternative (with dosage and Duration) Comments Puerperal sepsis: defined as: “‘a serious infection of the genital tract which occurs within 42 days of delivery” Inj Piperacillin- tazobactam 4.5g IV q6h for 7-14 days Clindamycin 600-900mg IV q8h + Gentamicin 5mg/kg IV OD (if penicillin allergic) for 7- 14 days Puerperal sepsis in Septic Shock Imipenem-cilastatin 500mg IV q6h / Meropenem 1g IV q8h for 7 -14 days Consider optimum and appropriate antibiotics like Vancomycin 1g BD, or Teicoplanin 400mg q12h for 3 doses followed by 400mg OD to cover MRSA with a total duration of therapy for 14 days. For common etiological agents of puerperal sepsis, see Annexure B.6. Additional Information: | 135 | definition | 0.980 | https://ncdc.mohfw.gov.in/uploads/pdf/amr17.pdf | Type of Infection First Line (with Dosage and Duration) Alternative (with dosage and Duration) Comments Puerperal sepsis: defined as: “‘a serious infection of the genital tract which occurs within 42 days of delivery” Inj Piperacillin- tazobactam 4.5g IV q6h for 7-14 days Clindamycin 600-900mg IV q8h + Gentamicin 5mg/kg IV OD (if penicillin allergic) for 7- 14 days Puerperal sepsis in Septic Shock Imipenem-cilastatin 500mg IV q6h / Meropenem 1g IV q8h for 7 -14 days Consider optimum and appropriate antibiotics like Vancomycin 1g BD, or Teicoplanin 400mg q12h for 3 doses followed by 400mg OD |
Read straight from the file — download or use the API URL for the full dataset.
| 18 |
| page=18,block=2 |
| 0.700 |
| valid |
| 55 |
| page=55,block=2 |
| 0.700 |
| valid |
| 50 |
| page=50,block=18 |
| 0.700 |
| valid |